Debt-to-equity of Twist Bioscience Corp from 30 Jun 2019 to 31 Dec 2025

Taxonomy & unit: ratio: x
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
Summary: Twist Bioscience Corp quarterly Debt-to-equity in x history and change rate from 30 Jun 2019 to 31 Dec 2025.
Twist Bioscience Corp Debt-to-equity for the quarter ending 31 Dec 2025 was 0.36x, a 23% increase year-over-year.

Debt-to-equity, Quarterly (x)

Debt-to-equity, YoY Quarterly Change (%)

Twist Bioscience Corp Quarterly Debt-to-equity (x)

Period	Value	YoY Chg	Change %	Date
Q4 2025	0.36x	+0.07x	+23%	31 Dec 2025
Q3 2025	0.35x	+0.08x	+28%	30 Sep 2025
Q2 2025	0.33x	+0.07x	+29%	30 Jun 2025
Q1 2025	0.32x	+0.08x	+32%	31 Mar 2025
Q4 2024	0.29x	+0.06x	+27%	31 Dec 2024
Q3 2024	0.27x	+0.04x	+20%	30 Sep 2024
Q2 2024	0.26x	+0.04x	+17%	30 Jun 2024
Q1 2024	0.24x	+0.03x	+15%	31 Mar 2024
Q4 2023	0.23x	+0.03x	+15%	31 Dec 2023
Q3 2023	0.23x	+0.02x	+8.3%	30 Sep 2023
Q2 2023	0.22x	+0.01x	+6.4%	30 Jun 2023
Q1 2023	0.21x	+0x	+1.9%	31 Mar 2023
Q4 2022	0.2x	+0.01x	+7.4%	31 Dec 2022
Q3 2022	0.21x	+0.06x	+42%	30 Sep 2022
Q2 2022	0.21x	+0.07x	+51%	30 Jun 2022
Q1 2022	0.21x	+0.08x	+62%	31 Mar 2022
Q4 2021	0.19x	+0.04x	+23%	31 Dec 2021
Q3 2021	0.15x	-0.11x	-43%	30 Sep 2021
Q2 2021	0.14x	-0.14x	-51%	30 Jun 2021
Q1 2021	0.13x	-0.18x	-59%	31 Mar 2021
Q4 2020	0.15x	-0.18x	-53%	31 Dec 2020
Q3 2020	0.26x	+0.06x	+29%	30 Sep 2020
Q2 2020	0.28x	-0.19x	-41%	30 Jun 2020
Q1 2020	0.31x			31 Mar 2020
Q4 2019	0.33x			31 Dec 2019
Q3 2019	0.2x			30 Sep 2019
Q2 2019	0.47x			30 Jun 2019

* An asterisk sign (*) next to the value indicates that the value is likely invalid.